PMID: 3757473Sep 1, 1986Paper

Clinical importance of polymicrobial bacteremia

Diagnostic Microbiology and Infectious Disease
M P WeinsteinJ R Murphy

Abstract

Ninety-one episodes of polymicrobial bacteremia and fungemia were compared with 407 unimicrobial episodes to assess differences in the microbiological, epidemiological, and clinical features of the two syndromes. Enterobacteriaceae, nongroup A streptococci, anaerobic bacteria, and pseudomonads were disproportionately common in polymicrobial bacteremia. Polymicrobial episodes were significantly more likely to be hospital-acquired, to emanate from bowel or multiple foci, and to occur in patients with nonhematologic malignancies or multiple underlying diseases. Deaths directly related to sepsis were twofold higher in polymicrobial versus unimicrobial bacteremia. Factors associated with increased mortality in polymicrobial sepsis included age greater than 40 yr; absent or diminished febrile response to sepsis; absolute granulocytopenia; inadequate antimicrobial therapy for all microorganisms isolated; and a primary focus of infection in the bowel, the respiratory tract, an abscess, or an occult site. The occurrence and type of polymicrobial bacteremia can suggest a source of sepsis as well as additional diagnostic and therapeutic maneuvers.

References

May 1, 1979·The American Journal of the Medical Sciences·B F IssellG P Bodey
Nov 1, 1977·Antimicrobial Agents and Chemotherapy·D M HahnP H Wiernik
Apr 1, 1979·The American Journal of Medicine·L J KiltonR H Parker
May 1, 1977·The American Journal of Medicine·C SingerD Armstrong
Dec 1, 1977·Archives of Internal Medicine·U Setia, P A Gross
Sep 1, 1976·The American Journal of Medicine·J E GalpinL B Guze
Nov 1, 1976·Archives of Internal Medicine·M E PlautE S Henderson
Jul 1, 1974·The Journal of Pediatrics·D E DietzmanF D Schoenknecht
Sep 1, 1970·Annals of Internal Medicine·P E Hermans, J A Washington
Sep 1, 1971·The Journal of Infectious Diseases·R L MyerowitzT F O'Brien
Aug 26, 1965·The New England Journal of Medicine·H D HochsteinV M Young
Apr 1, 1969·Archives of Internal Medicine·A R FeinsteinC R Schimpff
May 1, 1969·Archives of Internal Medicine·A R FeinsteinC R Schimpff
Dec 1, 1965·The American Journal of Medicine·U G Hodgin, J P Sanford
Feb 1, 1984·The American Journal of Medicine·M P Weinstein, L B Reller
Mar 1, 1984·American Journal of Diseases of Children·G T Frommell, J K Todd
Mar 1, 1980·The American Journal of Medicine·B E KregerW R McCabe
Mar 1, 1980·The American Journal of Medicine·B E KregerW R McCabe

❮ Previous
Next ❯

Citations

Jan 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·D CoullioudC Lasset
Nov 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D PittetR P Wenzel
Dec 15, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S SanchoJ M Nogueira
Apr 1, 1996·Diagnostic Microbiology and Infectious Disease·G E HollickB Martin
Dec 8, 2000·Diagnostic Microbiology and Infectious Disease·R L LarkJ J Plorde
Jan 25, 2003·Diagnostic Microbiology and Infectious Disease·Suzanne PulimoodPranatharthi Chandrasekar
Oct 29, 1998·Diagnostic Microbiology and Infectious Disease·C WendtL A Herwaldt
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C Wendt, W J Grunwald
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia JensenEmilio Bouza
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P WeinsteinL B Reller
Mar 29, 2013·The Journal of Antimicrobial Chemotherapy·Emilio BouzaMarta Rodríguez-Créixems
Jun 1, 1995·Critical Care Medicine·K C SasseT W Hu
Mar 12, 2003·American Journal of Therapeutics·Walid F KhayrRohiya H Latif
Apr 10, 2008·The Pediatric Infectious Disease Journal·Deena SutterJudith Epstein
Dec 24, 2010·Journal of Clinical Microbiology·Agnès LefortUNKNOWN COLIBAFI Group
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin J DownesSamir S Shah
Apr 21, 2009·Diagnostic Microbiology and Infectious Disease·Heather L NaceDionissios Neofytos
Nov 3, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Jiun-Nong LinHsi-Hsun Lin
Feb 1, 1988·The Journal of Hospital Infection·S Sutherland
Apr 16, 2016·American Journal of Infection Control·Abdalhamid M LagnfMichael J Rybak
Sep 24, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Matthew J BizzarroPatrick G Gallagher
Aug 31, 2016·Diagnostic Microbiology and Infectious Disease·Riad KhatibLaurence Briski
Feb 1, 1993·The British Journal of Surgery·A L Widdison, N D Karanjia
Aug 28, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jessica RenoJesse T Jacob
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·M ArpiS O Larsen
Jul 6, 2019·Frontiers in Medicine·Sien OmbeletLiselotte Hardy
May 29, 2020·Antimicrobial Resistance and Infection Control·Cheng ZhengGensheng Zhang
Oct 7, 2020·The Journal of Antimicrobial Chemotherapy·Stacey S ChernyUri Obolski
Jan 10, 2021·International Journal of Molecular Sciences·Giovanna BatoniSemih Esin
Oct 1, 1989·Clinical Microbiology Reviews·C S Bryan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.